معرفی
Dr. Marjorie Solomon is the Oates Endowed Professor of Psychiatry at the University of California-Davis, serving as Associate Director of the MIND Institute and the Imaging Research Center. Her research focuses on cognitive development in autistic children, adolescents, and young adults, employing neuropsychological and fMRI methodologies. She leads a clinical trial evaluating cognitive behavioral therapy (CBT) and medication efficacy in ASD-anxiety comorbidity, using fMRI as a biomarker. As co-Director of the NIMH T-32 Autism Research Training Program, she trains future researchers.
Her work examines neural and behavioral predictors of cognitive development, internalizing problems, and social determinants of health in autism. Key interests include sex differences in brain development, cortical thickness variations, and white matter pathways influencing language outcomes. She investigates sensory processing, decision-making under uncertainty, and the relationship between symptom severity changes and psychopathology.
Dr. Solomon has secured a $3.8M NIMH R01 grant for studying neural predictors in ASD. Her research spans over 20 years, with publications addressing fMRI biomarkers, autism phenotypes, and interventions like the ACCESS program for young adults. She explores intersectionality in Black/African American autistic populations and machine learning approaches to functional impairment classification.
Her clinical contributions include pioneering the STAAR trial for anxiety treatment and evaluating oxytocin’s effects in primate models. She emphasizes translating neuroimaging findings into actionable clinical strategies for improving adaptive functioning and mental health outcomes in neurodiverse populations.
